COVID-19 and the Kidney Community: Coalescing in Crisis

Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations

COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.

Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"

The coronavirus disease 2019 (COVID-19) pandemic constitutes a global health emergency. Currently, there are no completely effective therapeutic medications for the management of this outbreak. The cytokine storm is a hyperinflammatory medical condition due to excessive and uncontrolled release of pro-inflammatory cytokines in patients suffering from severe COVID-19, leading to the development of acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) and even mortality. Understanding the pathophysiology of COVID-19 can be helpful for the treatment of patients. Evidence suggests that the levels of tumor necrosis factor alpha (TNF-α) and interleukin (IL)-1 and IL-6 are dramatically different between mild and severe patients, so they may be important contributors to the cytokine storm. Several serum markers can be predictors for the cytokine storm. This review discusses the cytokines involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, focusing on interferons (IFNs) and ILs, and whether they can be used in COVID-19 treatment. Moreover, we highlight several microRNAs that are involved in these cytokines and their role in the cytokine storm caused by COVID-19.

Cardiac Surgery-Enhanced Recovery Programs Modified for COVID-19: Key Steps to Preserve Resources, Manage Caseload Backlog, and Improve Patient Outcomes

Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic

The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors

CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2

Rear Window—What Can the Gut Tell Us About Long-COVID?

Implications of the COVID-19 Pandemic for Pediatric Primary Care Practice in Europe

De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?

Gut Involvement by COVID-19

Plasma exchange and COVID 19

Asthma, biologics, corticosteroids, and coronavirus disease 2019

COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past